Latest news
Loading news…
BioVectra offers contract development and manufacturing capacity for intermediates and active pharmaceutical ingredients.
BioVectra was acquired by Agilent Technologies in 2024 for $925M.
Total Funding
Available in Pro Last Funding
Available in Pro Acquisitions
0
Monthly Visits
Available in Pro Contacts
322
Company Details
Funding & Financials
Pro- Total funding
- Funding rounds
- Last funding
- Last funding type
- Last funding date
- Funding status
- Total equity funding
- Revenue range
Web Traffic
Pro- Monthly visits
- Global traffic rank
- 6-mo avg visits
- Visit duration (s)
- Pages / visit
- Bounce rate
- Rank change (mo)
Company Info
- Org types
- company
- HQ
- Charlottetown, Prince Edward Island, Canada
Key People at BioVectra
Chief Science Officer
Chief Commercial Officer
Founder
VP Strategic Projects
322
professional contacts at BioVectra
Contact execs at BioVectra →Explore 200,000+ acquisitions — free
Filter the full database across sectors, companies, dates, and deal sizes. No signup, no paywall.
Recent News related to BioVectra
Loading news…
FAQs about BioVectra
People who checked this page also checked these
Browse the full Acquirezy directory.